Zevra Announces Phase 2 IH Clinical Trial Results – Wake Up Narcolepsy Community Update
Dear Deb and the Wake Up Narcolepsy community, Today we announced positive top-line results from......
Free CME-Certified, On-Demand Webinar: Earn up to 1.0 AMA PRA Category 1 Credit™
Narcolepsy is a high-burden sleep disorder marked by heterogeneous presentations that can be subtle, difficult to detect, and (sometimes) even more difficult to manage. Join distinguished experts, Dr Kiran Maski and Dr Clete Kushida, as they clarify the path to narcolepsy diagnosis and treatment, including novel therapies that can help patients restore the balance between wake and sleep.
Expires: December 2024
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.
Online Support GroupsFree, online support groups worldwide for people with Narcolepsy and their families. |
National SummitThis one-day summit is for people with Narcolepsy, their families, educators, clinicians and researchers. |
Clinical TrialsPatient engagement in clinical trials help find new ways to treat individuals with Narcolepsy. |
Annual Family WeekendChildren & Teens with Narcolepsy can meet others experiencing the same symptoms and challenges. |
Join Our TeamDo you share our passion for advocating on behalf of those with Narcolepsy? |
Dear Deb and the Wake Up Narcolepsy community, Today we announced positive top-line results from......
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering......
Since inception in 2008, countless women have contributed to the mission and success of Wake......
As Sleep Awareness Week 2024 approaches, taking place March 10th-16th, Wake Up Narcolepsy has very......